Clinical Trial: Azilect + Antidepressant Chart Review
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Investigation of the Occurrence of Serotonin Toxicity in Parkinson's Disease (PD) Patients Treated Concomitantly With Rasagiline and Antidepressants, Using Retrospective Chart Review
Brief Summary: To identify the occurrence of serotonin toxicity in Parkinson's Disease (PD) patients receiving antidepressant therapy and rasagiline, compared to those receiving rasagiline without antidepressant medications and compared to PD patients receiving antidepressants, but not rasagiline.
Detailed Summary:
Sponsor: Teva Pharmaceutical Industries
Current Primary Outcome: The frequency of serotonin toxicity, as determined by the Adjudication Committee will be calculated for each Group. The primary comparison will be Group R+AD vs. Group R and vs. Group AD [ Time Frame: 9 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Teva Pharmaceutical Industries
Dates:
Date Received: August 6, 2009
Date Started: July 2009
Date Completion:
Last Updated: February 2, 2017
Last Verified: February 2017